Colistin (polymyxin E) Inhalation Solution (nebulizer) Generics - Manufacturers & Suppliers
Coly-Mycin M(US)
| Product/Composition:- | Colistin (Polymyxin E) Inhalation Solution (Nebulizer) |
|---|---|
| Strength:- | 75 mg/2 mL |
| Form:- | Inhalation Solution (Nebulizer) |
| Reference Brands:- | Coly-Mycin M(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Colistin inhalation solution disrupts bacterial cell membranes by binding to lipopolysaccharides, causing leakage and bacterial death. It effectively treats resistant Pseudomonas aeruginosa lung infections in cystic fibrosis patients, providing targeted, rapid bacterial eradication, improved lung function, and reduced exacerbations with minimal systemic absorption for safe, long-term pulmonary therapy.
Colistin (Polymyxin E) inhalation solution is approved in the EU and US for treating Pseudomonas aeruginosa lung infections in cystic fibrosis patients. In Europe, brands like Colobreathe are regulated by EMA, supported by dossiers on safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, quality practices, and pharmacovigilance plans for approval and safety monitoring. Due to its specialized pulmonary use, strict regulations on dosing, storage, and safety follow. For expert regulatory support and seamless market entry, visit PharmaTradz. We ensure compliance with European and US standards for safe, effective inhalation therapy.